Latest filing published 23 Jun 2017 for Mylan II B.V., €53k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Douglas J. Leech discloses dealings in 4 companies, chiefly Mylan Laboratories Inc, Centra Financial Holdings Inc and United Bankshares Inc/wv. We count 75 filings; the first trade dates from 15 April 2008 and the latest from 22 June 2017.
On the open market, the record shows 15 purchases worth €2.0M and 15 sales worth €6.1M. The net balance comes to €4.1M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 27 option exercises.
Half of the purchases are above €75k and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -0.3%. These figures describe past trades and do not predict future prices.
Most recently, on 23 June 2017, the filings show an option exercise in Mylan II B.V. The last purchase on record was published on 19 February 2016, which is 3,900 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 72 declarations